An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 7,683 | 7,594 | 6,932 | 4,998 | 2,050 |
| Operating Income | -7,683 | -7,594 | -6,932 | -4,998 | -2,050 |
| Other Income | 28 | 49 | -11 | -9 | 2 |
| Pre-tax Income | -7,655 | -7,545 | -6,943 | -5,007 | -2,048 |
| Net Income Continuous | -7,655 | -7,545 | -6,943 | -5,007 | -2,048 |
| Net Income | $-7,655 | $-7,545 | $-6,943 | $-5,007 | $-2,048 |
| EPS Basic Total Ops | -2.98 | -3.60 | -3.35 | -2.62 | -1.07 |
| EPS Basic Continuous Ops | -2.41 | -2.86 | -2.63 | -1.90 | -0.78 |
| EPS Diluted Total Ops | -2.98 | -3.60 | -3.35 | -2.62 | -1.07 |
| EPS Diluted Continuous Ops | -2.41 | -2.86 | -2.63 | -1.90 | -0.78 |
| EBITDA(a) | $-7,682 | $-7,571 | $-6,913 | $-4,998 | $-2,050 |